Targeted Strategies for Today's Evolving Markets

MissionIR Blog

VolitionRx Ltd. (VNRX) Starts Presentation at 2015 Marcum MicroCap Conference

Posted on May 28, 2015 by MissionIR

VolitionRx is a clinical-stage life sciences company that focuses on developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases. The company is involved in the development of 20 epigenetic NuQ blood assays based on its Nucleosomics biomarker platform. It develops two blood assays in the NuQ-X family to detect the presence of cancer by detecting nucleosomes containing specific nucleotides; and three blood tests in the NuQ-V family to detect cancer. For more information visit the company website at www.volitionrx.com

The Marcum MicroCap Conference is a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The two-day 2016 conference will include feature presentations by CEOs and CFOs from seven principal industry sectors, expert panels moderated by industry leaders, and the opportunity to meet with management of presenting companies on a one-on-one basis. Marcum is partnered with KCSA Strategic Communications to present this year's Marcum MicroCap Conference.
This entry was posted in Marcum MicroCap. Bookmark the permalink.

Comments are closed.